3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
7
Ovarian Neoplasms
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Sarcoma
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Kidney Neoplasms
1
Colorectal Neoplasms
1
Breast Neoplasms, Male
1
Interventions
Docetaxel
35
pembrolizumab
32
Nivolumab
27
enzalutamide
20
Prednisone
20
Sunitinib
16
Cyclophosphamide
16
aldesleukin
14
Zoledronic Acid
13
Interleukin-2
13
Gemcitabine
13
Bevacizumab
13
Specimen Handling
12
Ipilimumab
12
Radiosurgery
11
Everolimus
11
Androgen Antagonists
11
Abiraterone Acetate
11
fludarabine
10
Sorafenib
10
Radiotherapy
10
Paclitaxel
10
Magnetic Resonance Spectroscopy
10
pazopanib
9
abiraterone
9
Doxorubicin
8
Carboplatin
8
Biopsy
8
avelumab
7
temsirolimus
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Genetic Counseling
×
Genitourinary
×
Clear all
NCT03503097
2025-10-01
GENTleMEN
University of Washington
Terminated
799 enrolled